Lapatinib dysregulates HER2 signaling and impairs the viability of human uveal melanoma cells.
Saved in:
| Title: | Lapatinib dysregulates HER2 signaling and impairs the viability of human uveal melanoma cells. |
|---|---|
| Authors: | Shu W; The University of Sydney, Sydney Pharmacy School, Faculty of Medicine and Health NSW 2006, Australia.; Department of Pharmacy, Affiliated Cancer Hospital & Institute of Guangzhou Medical University, Guangdong Province 511400, China., Wang JZ; The University of Sydney, Sydney Pharmacy School, Faculty of Medicine and Health NSW 2006, Australia., Zhu X; Key Laboratory of Nuclear Medicine, Ministry of Health, Jiangsu Key Laboratory of Molecular Nuclear Medicine, Jiangsu Institute of Nuclear Medicine, Wuxi, Jiangsu Province 214063, China., Wang K; Key Laboratory of Nuclear Medicine, Ministry of Health, Jiangsu Key Laboratory of Molecular Nuclear Medicine, Jiangsu Institute of Nuclear Medicine, Wuxi, Jiangsu Province 214063, China., Cherepanoff S; SydPath, Department of Anatomical Pathology, St Vincent's Hospital, Darlinghurst, NSW 2010, Australia., Conway RM; Ocular Oncology Unit, Sydney Eye Hospital and The Kinghorn Cancer Centre, Sydney, NSW 2006, Australia.; Save Sight Institute, The University of Sydney, Sydney, NSW 2006, Australia., Madigan MC; Save Sight Institute, The University of Sydney, Sydney, NSW 2006, Australia.; School of Optometry and Vision Sciences, University of New South Wales, Sydney, NSW 2006, Australia., Lim LA; Ocular Oncology Unit, Sydney Eye Hospital and The Kinghorn Cancer Centre, Sydney, NSW 2006, Australia.; Save Sight Institute, The University of Sydney, Sydney, NSW 2006, Australia., Zhu H; Zhejiang Province Key Laboratory of Anti-Cancer Drug Research, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, Zhejiang Province 310058, China., Zhu L; Save Sight Institute, The University of Sydney, Sydney, NSW 2006, Australia., Murray M; The University of Sydney, Sydney Pharmacy School, Faculty of Medicine and Health NSW 2006, Australia., Zhou F; The University of Sydney, Sydney Pharmacy School, Faculty of Medicine and Health NSW 2006, Australia. |
| Source: | Journal of Cancer [J Cancer] 2023 Oct 16; Vol. 14 (18), pp. 3477-3495. Date of Electronic Publication: 2023 Oct 16 (Print Publication: 2023). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Ivyspring International Publisher Country of Publication: Australia NLM ID: 101535920 Publication Model: eCollection Cited Medium: Print ISSN: 1837-9664 (Print) Linking ISSN: 18379664 NLM ISO Abbreviation: J Cancer Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Links: – Type: pdflink Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 38021158 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Lapatinib dysregulates HER2 signaling and impairs the viability of human uveal melanoma cells. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Shu+W%22">Shu W</searchLink>; The University of Sydney, Sydney Pharmacy School, Faculty of Medicine and Health NSW 2006, Australia.; Department of Pharmacy, Affiliated Cancer Hospital & Institute of Guangzhou Medical University, Guangdong Province 511400, China.<br /><searchLink fieldCode="AU" term="%22Wang+JZ%22">Wang JZ</searchLink>; The University of Sydney, Sydney Pharmacy School, Faculty of Medicine and Health NSW 2006, Australia.<br /><searchLink fieldCode="AU" term="%22Zhu+X%22">Zhu X</searchLink>; Key Laboratory of Nuclear Medicine, Ministry of Health, Jiangsu Key Laboratory of Molecular Nuclear Medicine, Jiangsu Institute of Nuclear Medicine, Wuxi, Jiangsu Province 214063, China.<br /><searchLink fieldCode="AU" term="%22Wang+K%22">Wang K</searchLink>; Key Laboratory of Nuclear Medicine, Ministry of Health, Jiangsu Key Laboratory of Molecular Nuclear Medicine, Jiangsu Institute of Nuclear Medicine, Wuxi, Jiangsu Province 214063, China.<br /><searchLink fieldCode="AU" term="%22Cherepanoff+S%22">Cherepanoff S</searchLink>; SydPath, Department of Anatomical Pathology, St Vincent's Hospital, Darlinghurst, NSW 2010, Australia.<br /><searchLink fieldCode="AU" term="%22Conway+RM%22">Conway RM</searchLink>; Ocular Oncology Unit, Sydney Eye Hospital and The Kinghorn Cancer Centre, Sydney, NSW 2006, Australia.; Save Sight Institute, The University of Sydney, Sydney, NSW 2006, Australia.<br /><searchLink fieldCode="AU" term="%22Madigan+MC%22">Madigan MC</searchLink>; Save Sight Institute, The University of Sydney, Sydney, NSW 2006, Australia.; School of Optometry and Vision Sciences, University of New South Wales, Sydney, NSW 2006, Australia.<br /><searchLink fieldCode="AU" term="%22Lim+LA%22">Lim LA</searchLink>; Ocular Oncology Unit, Sydney Eye Hospital and The Kinghorn Cancer Centre, Sydney, NSW 2006, Australia.; Save Sight Institute, The University of Sydney, Sydney, NSW 2006, Australia.<br /><searchLink fieldCode="AU" term="%22Zhu+H%22">Zhu H</searchLink>; Zhejiang Province Key Laboratory of Anti-Cancer Drug Research, College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, Zhejiang Province 310058, China.<br /><searchLink fieldCode="AU" term="%22Zhu+L%22">Zhu L</searchLink>; Save Sight Institute, The University of Sydney, Sydney, NSW 2006, Australia.<br /><searchLink fieldCode="AU" term="%22Murray+M%22">Murray M</searchLink>; The University of Sydney, Sydney Pharmacy School, Faculty of Medicine and Health NSW 2006, Australia.<br /><searchLink fieldCode="AU" term="%22Zhou+F%22">Zhou F</searchLink>; The University of Sydney, Sydney Pharmacy School, Faculty of Medicine and Health NSW 2006, Australia. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101535920%22">Journal of Cancer</searchLink> [J Cancer] 2023 Oct 16; Vol. 14 (18), pp. 3477-3495. <i>Date of Electronic Publication: </i>2023 Oct 16 (<i>Print Publication: </i>2023). – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Ivyspring+International+Publisher%22">Ivyspring International Publisher </searchLink><i>Country of Publication: </i>Australia <i>NLM ID: </i>101535920 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Print <i>ISSN: </i>1837-9664 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2218379664%22">18379664 </searchLink><i>NLM ISO Abbreviation: </i>J Cancer <i>Subsets: </i>PubMed not MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=38021158 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.7150/jca.88446 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 3477 Titles: – TitleFull: Lapatinib dysregulates HER2 signaling and impairs the viability of human uveal melanoma cells. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Shu W – PersonEntity: Name: NameFull: Wang JZ – PersonEntity: Name: NameFull: Zhu X – PersonEntity: Name: NameFull: Wang K – PersonEntity: Name: NameFull: Cherepanoff S – PersonEntity: Name: NameFull: Conway RM – PersonEntity: Name: NameFull: Madigan MC – PersonEntity: Name: NameFull: Lim LA – PersonEntity: Name: NameFull: Zhu H – PersonEntity: Name: NameFull: Zhu L – PersonEntity: Name: NameFull: Murray M – PersonEntity: Name: NameFull: Zhou F IsPartOfRelationships: – BibEntity: Dates: – D: 16 M: 10 Text: 2023 Oct 16 Type: published Y: 2023 Identifiers: – Type: issn-print Value: 1837-9664 Numbering: – Type: volume Value: 14 – Type: issue Value: 18 Titles: – TitleFull: Journal of Cancer Type: main |
| ResultId | 1 |
